{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:08:34Z","timestamp":1790402914982,"version":"4.1.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T00:00:00Z","timestamp":1313712000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0023109","type":"journal-article","created":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T20:25:12Z","timestamp":1313785512000},"page":"e23109","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":102,"title":["Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes"],"prefix":"10.1371","volume":"6","author":[{"given":"Valeria","family":"Santini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Girelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascia","family":"Campostrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Cortelezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Corbella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Reda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliviero","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Domenica","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes.","volume":"361","author":"A Tefferi","year":"2009","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0268-960X(09)70005-0","article-title":"Impact of iron overload in myelodysplastic syndromes.","volume":"23","author":"P Fenaux","year":"2009","journal-title":"Blood Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.","volume":"23","author":"L Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.thj.6200028","article-title":"Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?","volume":"1","author":"A Cortelezzi","year":"2000","journal-title":"Hematol J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and disorders of iron metabolism.","volume":"62","author":"T Ganz","year":"2011","journal-title":"Annu Rev Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1182\/blood-2009-07-234062","article-title":"Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?","volume":"114","author":"V Pullarkat","year":"2009","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis.","volume":"1","author":"A Donovan","year":"2005","journal-title":"Cell Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.","volume":"306","author":"E Nemeth","year":"2004","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism.","volume":"142","author":"MW Hentze","year":"2010","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.","volume":"13","author":"T Tanno","year":"2007","journal-title":"Nat Med"},{"key":"ref11","first-page":"184","article-title":"Growth differentiation factor 15 in erythroid health and disease.","volume":"17","author":"T Tanno","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3324\/haematol.2009.010322","article-title":"Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization.","volume":"94","author":"JJ Kroot","year":"2009","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jprot.2009.08.003","article-title":"Hepcidin assay in serum by SELDI-TOF-MS and other approaches.","volume":"73","author":"A Castagna","year":"2010","journal-title":"J Proteomics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2141.2008.07225.x","article-title":"Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis.","volume":"142","author":"A Winder","year":"2008","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2008.07455.x","article-title":"Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome.","volume":"144","author":"PT Murphy","year":"2009","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.","volume":"108","author":"BD Cheson","year":"2006","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms.","volume":"100","author":"JW Vardiman","year":"2002","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bcmd.2007.10.001","article-title":"Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis.","volume":"40","author":"C Bozzini","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e2706","DOI":"10.1371\/journal.pone.0002706","article-title":"Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry.","volume":"3","author":"DW Swinkels","year":"2008","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"329646","DOI":"10.1155\/2010\/329646","article-title":"Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF-MS.","volume":"2010","author":"N Campostrini","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"ref21","first-page":"727","article-title":"Hepcidin and iron-loading anemias.","volume":"91","author":"E Nemeth","year":"2006","journal-title":"Haematologica"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1196\/annals.1345.018","article-title":"Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use.","volume":"1054","author":"JB Porter","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/abio.1999.4216","article-title":"Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.","volume":"273","author":"I Gosriwatana","year":"1999","journal-title":"Anal Biochem"},{"key":"ref24","article-title":"The association of <italic>HFE<\/italic> and <italic>TMPRSS6<\/italic> genetic variants to iron and erythrocyte parameters is only in part dependent from serum hepcidin levels.","author":"M Traglia","year":"2011","journal-title":"J Med Genet"},{"key":"ref25","first-page":"1588","article-title":"Predicting survival and leukemic evolution in patients with myelodysplastic syndrome.","volume":"91","author":"L Malcovati","year":"2006","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(71)90240-3","article-title":"Iron in the heart: etiology and clinical significance.","volume":"51","author":"LM Buja","year":"1971","journal-title":"Am J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0145-2126(07)70461-7","article-title":"Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.","volume":"31","author":"N Gattermann","year":"2007","journal-title":"Leuk Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ajh.21269","article-title":"Consensus statement on iron overload in myelodysplastic syndromes.","volume":"83","author":"JM Bennett","year":"2008","journal-title":"Am J Hematol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.leukres.2009.12.004","article-title":"Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des My\u00e9lodysplasies).","volume":"34","author":"C Rose","year":"2010","journal-title":"Leuk Res"},{"key":"ref30","first-page":"447","article-title":"Classification and diagnosis of iron overload.","volume":"83","author":"A Piperno","year":"1998","journal-title":"Haematologica"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4612a","DOI":"10.1182\/blood.V110.11.4612.4612","article-title":"Expression of genes regulating iron metabolism in hepatocyte cell-line HepG2 induced by sera from MDS patients.","volume":"110","author":"L Breda","year":"2007","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM198206243062504","article-title":"Perspectives in iron metabolism.","volume":"306","author":"CA Finch","year":"1982","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1182\/asheducation-2008.1.166","article-title":"Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes.","author":"M Cazzola","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.2008.07397.x","article-title":"Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia.","volume":"143","author":"R Mariani","year":"2008","journal-title":"Br J Haematol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-\u03b2 superfamily.","volume":"94","author":"MR Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2141.2008.07441.x","article-title":"Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts.","volume":"144","author":"JM Ramirez","year":"2009","journal-title":"Br J Haematol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCGENETICS.108.824870","article-title":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.","volume":"2","author":"T Kempf","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2009.08.041","article-title":"Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.","volume":"55","author":"SH Zaidi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2008-12-195503","article-title":"Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.","volume":"114","author":"T Tanno","year":"2009","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbagen.2008.09.004","article-title":"Ferritins: a family of molecules for iron storage, antioxidation and more.","volume":"1790","author":"P Arosio","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI.","volume":"363","author":"Y Gandon","year":"2004","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2004-01-0177","article-title":"Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.","volume":"105","author":"TG St Pierre","year":"2005","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbmt.2010.09.006","article-title":"Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation.","volume":"17","author":"P Armand","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2215\/CJN.01370209","article-title":"HFE mutations modulate the effect of iron stores and inflammation on serum hepcidin-25 in chronic hemodialysis patients.","volume":"4","author":"L Valenti","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3324\/haematol.2010.033449","article-title":"A time course of hepcidin response to iron challenge in HFE and TfR2 Haemochromatosis patients.","volume":"96","author":"D Girelli","year":"2010","journal-title":"Haematologica"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","article-title":"Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.","volume":"101","author":"E Nemeth","year":"2003","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.nutr.012809.104804","article-title":"Iron homeostasis and the inflammatory response.","volume":"30","author":"M Wessling-Resnick","year":"2010","journal-title":"Annu Rev Nutr"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia.","volume":"115","author":"BJ Sasu","year":"2010","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2010-06-289082","article-title":"Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo.","volume":"117","author":"M Poli","year":"2011","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0023109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T12:37:05Z","timestamp":1592829425000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0023109"}},"subtitle":[],"editor":[{"given":"Dan","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,19]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0023109","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,19]]}}}